Open Access Open Access  Restricted Access Subscription Access

Aluminium and Neuro-degeneration: Mechanism of Pathogenesis and Possible Strategies for Mitigation


Affiliations
1 Department of Zoology, Indira Gandhi National Tribal University, Amarkantak – 484887, Madhya Pradesh, India
2 Department of Biomedical Sciences, Bundelkhand University, Jhansi – 284128, Uttar Pradesh, India
 

One of the most abundant metal in our environment is aluminium (Al). Occupational exposure of humans to Al takes place during its extractions, processing and fabrications of articles of daily use. Al in drinking water and as well as its use in packaging & storage of food is also a potential source of exposure. Acute exposure of higher concentration or chronic exposure of low concentration of Al leads to its aggregation in various parts of the body, resulting in system toxicity. Brain is highly susceptible to Al accumulation toxicity. In humans, exposure of Al is a risk factor for the starting of Alzheimer Disease. The adverse effect of Al exposure on nervous system results in memory loss, balance problems and impairment of coordination. High level of Al in brain increases lipid peroxidation and oxidative stress and reduces antioxidant enzymes level. It also causes aggregation of amyloid beta proteins and formation of Neurofibrillary Tangles (NFTs) of tau proteins which finally leads to death of neuronal cell and neurotoxicity. Metabolism and excretion of heavy metals including Al is very difficult and its leads to accumulation. The chelation therapy has been proposed where the organic molecules like EDTA, Chlorogenic acid and GSH binds with the heavy metals and facilitates for their excretion from body. However, non-specific binding of these chelators is another major safety concern. Medicinal plants and their phytochemicals with multiple mechanism of action have been proposed as a very good alternative for ameliorating heavy metal induced toxicity. In addition to mild chelating activities, the phytochemicals have antioxidant, anti-inflammatory, cytokine modulatory and other specific actions for proving holistic neuro-protection on heavy metal exposure.

Keywords

Aluminium, Beta-amyloid, Chelation, Medicinal Plants, Neurodegeneration, Tau protein, ROS
User
Notifications
Font Size

  • Riihimäki V, Aitio A. Occupational exposure to aluminum and its biomonitoring in perspective. Critical Reviews in Toxicology. 2012;42(10):827–853. https://doi.org/10.3109/ 10408444.2012.725027. PMid:23013241
  • Nie J. Neurotoxicity of Aluminum. 1st ed. Singapore: Springer Nature Singapore Pte Ltd; c2018. Chapter 6, Exposure to Aluminum in Daily Life and Alzheimer’s Disease; p. 99–111. https://doi.org/10.1007/978-981-131370-7_6. PMid:30315451
  • Peters S, Reid A, Fritschi L, Klerk NDe, Musk AWB. Longterm effects of aluminium dust inhalation. Occupational and Environmental Medicine. 2013; 70(12):864–868. https:// doi.org/10.1136/oemed-2013-101487. PMid:24142983
  • Bondy SC. Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer’s disease and age-related neurodegeneration. NeuroToxicology. 2016;52(1):222–229. https://doi.
  • org/10.1016/j.neuro.2015.12.002. PMid:26687397
  • Crisponi G, Fanni D, Gerosa C, Nemolato S, Nurchi VM, Crespo-alonso M, et al. The meaning of aluminium exposure on human health and aluminium-related diseases. BioMol Concepts. 2013; 4(1):77–87. https://doi.org/10.1515/bmc-2012-0045. PMid:25436567
  • Li X, Zhang L, Zhu Y, Li Y. Dynamic analysis of exposure to aluminum and an acidic condition on bone formation in young growing rats. Environmental Toxicology and Pharmacology. 2011; 31(2):295-301. https://doi.org/10.1016/j.etap.2010.11.007. PMid:21787697
  • Tietz T, Lenzner A, Kolbaum AE, Zellmer S, Riebeling C, Gurtler R, et al. Aggregated aluminium exposure: risk assessment for the general population. Archives of Toxicology. 2019; 93(12):3503–3521. https://doi.org/10.1007/s00204-019-02599-z. PMid:31659427
  • Chappard D, Bizot P, Mabilleau G, Hubert L. Aluminum and bone: Review of new clinical circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie. 2016; 100(329):95–105. https://doi.org/10.1016/j.morpho.2015.12.001. PMid:26762722
  • Mahor G, Ali SA. An update on the role of medicinal plants in amelioration of aluminium toxicity. Bioscience Biotechnology Research Communications. 2015; 8(2):175– 188.
  • Klein JP, Mold M, Mery L, Cottier M, Exley C. Aluminum content of human semen: Implications for semen quality. Reproductive Toxicology. 2014; 50(8):43–48. https://doi.org/10.1016/j.reprotox.2014.10.001. PMid:25461904
  • Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. Journal of Toxicology and Environmental Health, Part B. 2007; 10:1–269. https://doi.org/10.1080/10937400701597766 PMid:18085482 PMCid:PMC2782734
  • Esparza JL, Gómez M, Domingo JL. Role of melatonin in aluminum-related neurodegenerative disorders: A review. Biological Trace Element Research. 2019; 188(1):60–67. https://doi.org/10.1007/s12011-018-1372-4. PMid:29732485
  • Yokel RA, McNamara PJ. Aluminium toxicokinetics: An updated mini review. Pharmacology & Toxicology. 2001; 88(4):159-167. https://doi.org/10.1034/j.1600-0773.2001.d01-98.x. PMid:11322172
  • Exley C. Human exposure to aluminium. Environmental Science Processes & Impacts. 2013; 15(10):1807–1816. https://doi.org/10.1039/C3EM00374D. PMid:23982047
  • Panossian A, Seo E, Efferth T. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine. 2019; 60(7):1–12. https://doi.org/10.1016/j.phymed.2019.152881. PMid:30987861
  • Kaneko N, Sugioka T, Sakurai H. Aluminum compounds enhance lipid peroxidation in liposomes: Insight into cellular damage caused by oxidative stress. Journal of Inorganic Biochemistry. 2007; 101(6):967–975. https://doi.org/10.1016/j.jinorgbio.2007.03.005. PMid:17467804
  • Bondy SC. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology. 2010; 31(5):575–581. https://doi.org/10.1016/j.neuro.2010.05.009.PMid:205537 58 PMCid:PMC2946821
  • Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. Oxidative Medicine and Cellular Longevity. 2017; 2017(7):1–11. https://doi.org/10.1155/2017/2525967
  • Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: Stuck in the middle of neurodegeneration. Journal of Alzheimer’s Disease. 2010; 20(S2):S357–S367. https://doi.org/10.3233/JAD-2010-100498. PMid:20421690
  • Go’mez M, Esparza JL, Nogue’s MR, Giralt M, Cabre’ M, Domingo JL. Pro-oxidant activity of aluminum in the rat hippocampus: Gene expression of antioxidant enzymes after melatonin administration.
  • Free Radical Biology & Medicine. 2005; 38(1):104–111. https://doi.org/10.1016/j.freeradbiomed.2004.10.009. PMid:15589378
  • Garcia T, Esparza JL, Nogue’s MR, Romeu M, Domingo JL, Go’mez M. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer’s disease after chronic exposure to aluminum. Hippocampus. 2010; 20(1):218–225. https://doi.org/10.1002/hipo.20612. PMid:19405147
  • Olmos G, Lladó J. Tumor necrosis factor alpha: A link between neuroinflammation and excito
  • toxicity. Mediators of Inflammation. 2014; 2014:1–13. https://doi.org/10.1155/2014/861231 PMid:24966471.
  • PMCid:PMC4055424
  • Danbolt NC. Glutamate uptake. Progress in Neurobiology. 2001; 65(1):1–105. https://doi.org/10.1016/S0301-0082(00)00067-8
  • Rainey-Smith SR, Andersson DA, Williams RJ, Rattray M. Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: Relevance to neurodegeneration. Journal of Neurochemistry. 2010; 113(3):692–703. https://doi.org/10.1111/j.1471-4159.2010.06634.x. PMid:20132465
  • Kim BW, Koppula S, Hong SS, Jeon SB, Kwon JH, Hwang BY, et al. Regulation of microglia activity by glaucocalyxin-a: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways. PLOS ONE. 2013; 8(2):1–11. https:// doi.org/10.1371/journal.pone.0055792. PMid:23393601 PMCid:PMC3564949
  • Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. The Journal of Pharmacology and Experimental Therapeutics. 2003; 304(1):1–7. https://doi.org/10.1124/jpet.102.035048
  • Bui TT, Nguyen TH. Natural product for the treatment of Alzheimer’s disease. Journal of Basic and Clinical Physiology and Pharmacology. 2017; 28(5):413–423. https://doi.org/10.1515/jbcpp-2016-0147. PMid:28708573
  • Pirşcoveanu DFV, Pirici I, Tudorica V, Balseanu TA, Albu VC, Bondari S, et al. Tau protein in neurodegenerative diseases - A review. Romanian Journal of Morphology and Embryology. 2017; 58(4):1141–1150.
  • Wang Y, Tang XC, Zhang HY. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. Journal of Neuroscience Research. 2012; 90(2):508–517. https://doi.org/10.1002/jnr.22775. PMid:22002568
  • Saljooghi AS. Chelation of aluminum by combining deferasirox and deferiprone in rats. Toxicology and Industrial Health. 2012; 28(8):740–745. https://doi.org/10.1177/0748233711422731. PMid:22025507
  • Ferrero ME. Rationale for the successful management of EDTA chelation therapy in human burden by toxic metals. BioMed Research International. 2016; 2016:1–13.
  • https://doi.org/10.1155/2016/8274504. PMid:27896275 PMCid:PMC5118545
  • Fulgenzi A, Ferrero ME. EDTA chelation therapy for the treatment of neurotoxicity. International Journal of Molecular Sciences. 2019; 20(5):1–16.
  • Wang X, Fan X, Yuan S, Jiao W, Liu B, Cao J, et al. Chlorogenic acid protects against aluminium-induced cytotoxicity through chelation and antioxidant actions in primary hippocampal neuronal cells. Food and Function. 2017; 8(8):2924–2934. https://doi.org/10.1039/ C7FO00659D. PMid:28745369
  • Lee M, Cho S, Roh K, Chae J, Park JH, Park J, et al. Glutathione alleviated peripheral neuropathy in oxaliplatin-treated mice by removing aluminum from dorsal ischolar_main ganglia. American Journal of Translational Research. 2017; 9(3):926–939.
  • Pandey S, Sharma V, Chaudhary AK. Chelation therapy and chelating agents of Ayurveda. International Journal of Green Pharmacy. 2016; 10(3):143–150.
  • Elufioye TO, Berida TI, Habtemariam S. Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms. Evidence-Based Complementary and Alternative Medicine. 2017; 2017:1– 27. https://doi.org/10.1155/2017/3574012. PMid:28904554 PMCid:PMC5585568
  • Ahmed HH, Booles HF, Khalil WKB, Ashmaoui HMEl, Othman SM. Possible therapeutic role of Jasonia Candicans and Jasonia Montana extracts in the regression of Alzheimer’s disease in experimental model. American Journal of Biochemistry and Biotechnology. 2013; 9(2):144–161.
  • https://doi.org/10.3844/ajbbsp.2013.144.161
  • Chitra B, Ramaswamy RS. An overview on the role of Siddha practices in the prevention and management of age related neurodegenerative disorders with special reference to senile dementia. Indo American Journal of Pharmaceutical Research. 2015; 5(4):1510–1521.
  • Mohebbati R, Khazdair MR, Hedayati M. Neuroprotective Effects of medicinal plants and their constituents on different induced neurotoxicity methods: A review. Journal of Reports in Pharmaceutical Sciences. 2017; 6(1):34–50.
  • Huang W, Cheng P, Yu K, Han Y, Song M, Li Y. Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells. Biomedicine & Pharmacotherapy. 2017; 96(12):1–6. https://doi.org/10.1016/j.biopha.2017.09.114. PMid:28961505
  • Kim J, Park S, Ha H, Moon C, Shin T, Kim J, et al. Opuntia ficus-indica attenuates neuronal injury in in vitro and in vivo models of cerebral ischemia. Journal of Ethnopharmacology. 2006; 104(1–2):257–262. https://doi.org/10.1016/j.jep.2005.09.017. PMid:16243466
  • Gambino G, Allegra M, Sardo P, Attanzio A, Tesoriere L, Livrea MA, et al. Brain distribution and modulation of neuronal excitability by indicaxanthin from Opuntia ficus indica administered at nutritionally-relevant amounts. Frontiers in Aging Neuroscience. 2018; 10(133):1–11.
  • https://doi.org/10.3389/fnagi.2018.00133. PMid:29867444 PMCid:PMC5954040
  • Khazdair MR, Anaeigoudari A, Hashemzehi M, Mohebbati R. Neuroprotective potency of some spice herbs, a literature review. Journal of Traditional and Complementary Medicine. 2019; 9(2):98–105. https://doi.org/10.1016/j.jtcme.2018.01.002. PMid:30963044 PMCid:PMC6435951
  • Kumar GP, Khanum F. Neuroprotective potential of phytochemicals. Pharmacognosy Review. 2012; 6(12):81–90. https://doi.org/10.4103/0973-7847.99898. PMid:23055633 PMCid:PMC3459459
  • Pereira DM, Valentão P, Pereira JA, Andrade PB. Phenolics: From chemistry to biology. Molecules. 2009; 14(6):2202– 2211. https://doi.org/10.3390/molecules14062202. PMCid:PMC6254163
  • Symonowicz M, Kolanek M. Flavonoids and their properties to form chelate complexes. Biotechnology and Food Sciences. 2012; 76(1):35–41.

Abstract Views: 464

PDF Views: 171




  • Aluminium and Neuro-degeneration: Mechanism of Pathogenesis and Possible Strategies for Mitigation

Abstract Views: 464  |  PDF Views: 171

Authors

Vikas Pankaj Bhargava
Department of Zoology, Indira Gandhi National Tribal University, Amarkantak – 484887, Madhya Pradesh, India
Aashish Kumar Netam
Department of Zoology, Indira Gandhi National Tribal University, Amarkantak – 484887, Madhya Pradesh, India
Rambir Singh
Department of Biomedical Sciences, Bundelkhand University, Jhansi – 284128, Uttar Pradesh, India
Poonam Sharma
Department of Zoology, Indira Gandhi National Tribal University, Amarkantak – 484887, Madhya Pradesh, India

Abstract


One of the most abundant metal in our environment is aluminium (Al). Occupational exposure of humans to Al takes place during its extractions, processing and fabrications of articles of daily use. Al in drinking water and as well as its use in packaging & storage of food is also a potential source of exposure. Acute exposure of higher concentration or chronic exposure of low concentration of Al leads to its aggregation in various parts of the body, resulting in system toxicity. Brain is highly susceptible to Al accumulation toxicity. In humans, exposure of Al is a risk factor for the starting of Alzheimer Disease. The adverse effect of Al exposure on nervous system results in memory loss, balance problems and impairment of coordination. High level of Al in brain increases lipid peroxidation and oxidative stress and reduces antioxidant enzymes level. It also causes aggregation of amyloid beta proteins and formation of Neurofibrillary Tangles (NFTs) of tau proteins which finally leads to death of neuronal cell and neurotoxicity. Metabolism and excretion of heavy metals including Al is very difficult and its leads to accumulation. The chelation therapy has been proposed where the organic molecules like EDTA, Chlorogenic acid and GSH binds with the heavy metals and facilitates for their excretion from body. However, non-specific binding of these chelators is another major safety concern. Medicinal plants and their phytochemicals with multiple mechanism of action have been proposed as a very good alternative for ameliorating heavy metal induced toxicity. In addition to mild chelating activities, the phytochemicals have antioxidant, anti-inflammatory, cytokine modulatory and other specific actions for proving holistic neuro-protection on heavy metal exposure.

Keywords


Aluminium, Beta-amyloid, Chelation, Medicinal Plants, Neurodegeneration, Tau protein, ROS

References





DOI: https://doi.org/10.18311/ajprhc%2F2021%2F26174